Directa Plus (LON:DCTA) Reaches New 52-Week Low – Should You Sell?

Directa Plus Plc (LON:DCTAGet Free Report)’s stock price hit a new 52-week low during trading on Monday . The company traded as low as GBX 6 ($0.07) and last traded at GBX 6.50 ($0.08), with a volume of 22801 shares changing hands. The stock had previously closed at GBX 6 ($0.07).

Directa Plus Price Performance

The company has a market cap of £6.79 million, a price-to-earnings ratio of -108.33 and a beta of 0.74. The company has a 50-day simple moving average of GBX 7.97 and a 200-day simple moving average of GBX 13.05. The company has a debt-to-equity ratio of 57.75, a quick ratio of 4.88 and a current ratio of 1.50.

About Directa Plus

(Get Free Report)

Directa Plus has a unique and patented, chemical-free production process of pristine graphene nanoplatelets (GNPs), tailored to our partners’ and customers’ requirements. The manufacturing model is flexible and scalable. We have a pioneering vision of the applications of G+® Graphene Plus in different industrial sectors.

See Also

Receive News & Ratings for Directa Plus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Directa Plus and related companies with MarketBeat.com's FREE daily email newsletter.